SK Biopharmaceuticals expands radiopharmaceutical therapy portfolio with second in-licensed candidate from Wisconsin Alumni Research Foundation
New addition strengthens SK Biopharmaceuticals’ radiopharmaceutical therapy portfolio and reinforces its R&D capabilities through global partnerships and value chain integration SEOUL, South Korea, November 27, 2025 – SK Biopharmaceuticals, CO.,…